Sun.Jan 12, 2025

article thumbnail

STAT+: DOJ seeks interviews with former UnitedHealth Group doctors

STAT

The Justice Department is interviewing former UnitedHealth Group physicians about their experiences working at practices owned by the health care giant, two sources with knowledge of the inquiries told STAT.

Insurance 145
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

It's officially a new year for the healthcare industry, as biopharma and health system executives, investors, reporters and others make the annual trek to the Westin St. Francis in San Francisco for the J.P. Morgan Healthcare Conference.

118
118
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

National Pharmacists Day: Drug Topics’ Pharmacist Interviews from the Past Year

Drug Topics

To celebrate National Pharmacists Day on January 12, Drug Topics gathered its pharmacist interviews from the past year, exploring expert industry insights in a variety of topics.

98
article thumbnail

Updates in Cancer Prevention and Screening for 2025: A Pharmacist Primer

Pharmacy Times

Pharmacists play a vital role in cancer prevention and early detection by educating patients on risk factors, counseling on screening guidelines, and promoting adherence to evidence-based recommendations for common cancers, such as breast, cervical, colorectal, lung, prostate, and skin cancer.

81
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Drug Interactions In Diabetes Care – Our Top 10

Med Ed 101

Treating patients with type II diabetes often requires an array of medications to control blood sugar and manage various comorbidities. Understanding possible drug-drug and drug-disease interactions between medications is extremely important for optimizing medication therapy, preventing adverse effects, and overall improving patient outcomes in diabetes patients.

69
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please submit the good newsor the badfrom your shop, and we will feature it here at the end of each week.

59

More Trending

article thumbnail

FDA’s Issues Draft Guidance on Accelerated Approval: A Substantial Evidentiary and Procedural Overhaul to this High-Profile Pathway

The FDA Law Blog

By Charles G. Raver & James E. Valentine & Ellis Unger & Frank J. Sasinowski On December 5, 2024, FDA published a new draft guidance on accelerated approval providing a much needed and substantial update to its guidance on the pathway. FDAs application and use of accelerated approval has evolved dramatically since it was first developed by the Agency to help address the HIV/AIDS epidemic in the late 1980s.

FDA 64
article thumbnail

Episode 596: PREMIUM – A painful podcast about methotrexate and walking for pain

Therapeutics Education Collaboration

This content is for members only. Visit the site and log in/register to read. In episode 596, Mike and James talk in a PREMIUM way about three trials that used methotrexate for osteoarthritis and walking for back pain. Nothing miraculous but there seems to be an effect so have a listen.

40
article thumbnail

STAT+: Biogen CEO confirms he’s shopping for biotechs: ‘We will be doing deals’

STAT

SAN FRANCISCO — Biogen would like to make additional biotech acquisitions in 2025 beyond Friday’s offer to buy its financially troubled partner Sage Therapeutics, chief executive Chris Viehbacher told me Sunday. “We will be doing deals — the size of those deals, I cannot say,” he said in an interview ahead of the J.P.

137
137